
Why Is Rapport Therapeutics, Inc. Common Stock (NASDAQ: RAPP) Stock Down Today?
Live update on RAPP's movement on the NASDAQ, with key data on price change, volume, technical indicators, sector trends, and analyst sentiment.
Rapport Therapeutics, Inc. Common Stock (NASDAQ: RAPP) Update
Rapport Therapeutics, Inc. Common Stock (NASDAQ: RAPP) Summary
Rapport Therapeutics, Inc. Common Stock (NASDAQ: RAPP) is trading down -1.95% at $39.66, reflecting a negative shift in investor sentiment today. The stock opened at $40.70 and has moved between $39.11 and $42.18 so far.
Trading volume is 616966, which is 70% above its average, and the price action suggests selling interest.
Technically, RAPP on the NASDAQ is trading below its 50-day moving average of $44.78 and above its 200-day moving average of $35.49, indicating short-term weakness but long-term strength.
Analyst sentiment is bullish. Meyka's AI assigns RAPP a grade of B (Overall moderate), reflecting its assessment of fundamentals and sentiment. Forecast models project potential returns of +17.07% in 1 month ($46.43), +45.11% in 1 year ($57.55), and +333.62% in 5 years ($171.97).
See full chart, check forecasting details, or see the AI grade breakdown to explore what's driving this stock's movement on the NASDAQ.
Stay informed and make better investment decisions.
RAPP (NASDAQ) Technical Signals
Trading below 50-day moving average ($44.78)
Trading over 200-day moving average ($35.49)
Analyst Recommendations (NASDAQ: RAPP)
Price Forecast
1 Month
$46.43
1 Year
$57.55
3 Years
$114.72
5 Years
$171.97
Is this change significant?
5-Day:-7.38%
1-Month:-17.79%
3-Month:+3.85%
What's next?
Next earnings date: 7/30/2025